PURSLANE HERB

I N S T R U C T I O N for medical use of the medicinal product SPORISHU HERB (POLYGONI AVICULARIS HERBA)

Composition:

Active substance: Sporishu herb (Polygoni avicularis herba);

1 pack contains: Sporishu herb (Polygoni avicularis herba) 100 g.

Pharmaceutical form. Cut and pressed herb.

Main physico-chemical properties: cylindrical pieces, 4 to 6 mm in diameter, 8–12 mm in length. Surface smooth, shiny, occasionally dull, marbled; ends uneven.

Color: brownish-green with light-yellow specks.

Pharmacotherapeutic group. Agents used in urology. ATC code G04BC.

Pharmacological properties.

Pharmacodynamics.

The biologically active substances of the herb prevent the formation and promote the excretion of urinary calculi in urolithiasis, enhance diuresis, increase the urinary excretion of excess sodium and chloride ions, enhance glomerular filtration and reduce tubular reabsorption in the kidneys, and decrease the permeability of blood vessel walls.

Clinical characteristics.

Indications.

Initial stages of urolithiasis; uric acid diathesis; postoperative period after removal of urinary stones; chronic renal failure; chronic glomerulonephritis, pyelonephritis, bladder inflammation in remission stage (as part of complex therapy).

Contraindications.

Thrombophlebitis; acute inflammatory diseases of kidneys and urinary bladder; changes in blood rheological properties; presence of urinary tract stones larger than 6 mm. Hypersensitivity to biologically active components of the drug.

Interaction with other medicinal products and other forms of interactions. Unknown.

Special precautions for use.

It is recommended to take the infusion through a straw to avoid contact with teeth (possible enamel dissolution and tooth damage).

Use during pregnancy or breastfeeding. Contraindicated.

Ability to affect reaction speed when driving or operating machinery. No effect.

Method of Administration and Dosage.

Place 1 tablespoon of cut and pressed herb into an enameled container, pour 200 mL of hot boiled water, cover with a lid, and place on a boiling water bath for 15 minutes. Cool at room temperature for 45 minutes, strain, and squeeze the residue into the strained infusion. Adjust the volume of the infusion to 200 mL with boiled water. Shake the infusion before use. Take warm, 2–3 times daily, 15–20 minutes before meals: adults—⅓–½ cup, children aged 14 years and older—¼ cup, children aged 12–14 years—2 tablespoons, aged 7–12 years—1 tablespoon.

Store the prepared infusion at 8–15°C for no more than 2 days.

Treatment duration—up to 20–25 days. Repeat courses (no more than 4 per year) should be conducted after a 10–12 day break.

Children. The drug may be used in children aged 7 years and older.

Overdose. No reports available.

Adverse reactions.

Allergic reactions (including rash, itching, hyperemia, skin swelling), renal colic. Prolonged use of the drug may lead to discoloration of dental enamel and impairment of bone tissue structure (osteoporosis).

Shelf life. 3 years.

Do not use after the expiry date stated on the packaging.

Storage conditions. Store in the original packaging at a temperature not exceeding 30 °C, in a place inaccessible to children.

Packaging. 100 g per carton with inner pouch.

Availability. Over-the-counter.

Manufacturer/Applicant. JSC "Lektravy," Ukraine.

Address of manufacturer and location of business activity/applicant's address.

Ukraine, 10001, Zhytomyr region, city of Zhytomyr, Kyivske shose, building 21.